Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs

Priori, 2011, Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis, Circ. Res., 108, 871, 10.1161/CIRCRESAHA.110.226845 Wehrens, 2003, FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death, Cell, 113, 829, 10.1016/S0092-8674(03)00434-3 van der Werf, 2012, Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments, Europace, 14, 175, 10.1093/europace/eur277 Wehrens, 2004, Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2, Science, 304, 292, 10.1126/science.1094301 Ye, 2012, Designing calcium release channel inhibitors with enhanced electron donor properties: stabilizing the closed state of ryanodine receptor type 1, Mol. Pharmacol., 81, 53, 10.1124/mol.111.074740 Watanabe, 2009, Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans, Nat. Med., 15, 380, 10.1038/nm.1942 Zhou, 2011, Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release, Nat. Med., 17, 1003, 10.1038/nm.2406 Echt, 1991, Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial, N. Engl. J. Med., 324, 781, 10.1056/NEJM199103213241201 Kannankeril, 2006, Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy, Proc. Natl. Acad. Sci. U. S. A., 103, 12179, 10.1073/pnas.0600268103 Li, 2012, Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice, Circ. Res., 110, 465, 10.1161/CIRCRESAHA.111.253229 Cerrone, 2005, Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor, Circ. Res., 96, e77, 10.1161/01.RES.0000169067.51055.72 Li, 2010, Programmed electrical stimulation in mice, J. Vis. Exp., 1730 van Oort, 2010, Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure, Circulation, 122, 2669, 10.1161/CIRCULATIONAHA.110.982298 Cheng, 2008, Calcium sparks, Physiol. Rev., 88, 1491, 10.1152/physrev.00030.2007 Knollmann, 2006, Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia, J. Clin. Invest., 116, 2510 Hilliard, 2010, Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass, J. Mol. Cell. Cardiol., 48, 293, 10.1016/j.yjmcc.2009.10.005 Wehrens, 2007, The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms?, Heart Rhythm., 4, 794, 10.1016/j.hrthm.2006.12.016 King, 2013, Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2-P2328S hearts, Acta Physiol (Oxford), 207, 308, 10.1111/apha.12006 Gyorke, 1997, Dual effects of tetracaine on spontaneous calcium release in rat ventricular myocytes, J. Physiol., 500, 297, 10.1113/jphysiol.1997.sp022021 Chelu, 2009, Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice, J. Clin. Invest., 119, 1940 Lehnart, 2004, Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak, Circulation, 109, 3208, 10.1161/01.CIR.0000132472.98675.EC Waddell-Smith, 2015, Physical and psychological consequences of left cardiac sympathetic denervation in long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia, Circ. Arrhythm. Electrophysiol., 8, 1151, 10.1161/CIRCEP.115.003159 Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in may 2013 and by ACCF, AHA, PACES, and AEPC in June 2013, Heart Rhythm., 10, 1932, 10.1016/j.hrthm.2013.05.014 Bannister, 2015, The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2, Circ. Res., 116, 1324, 10.1161/CIRCRESAHA.116.305347 Razavi, 2005, Safe and effective pharmacologic management of arrhythmias, Tex. Heart Inst. J., 32, 209 Kaneko, 1997, Inhibition of annexin V-dependent Ca2+ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative, Biochim. Biophys. Acta, 1330, 1, 10.1016/S0005-2736(97)00132-6 Kiriyama, 2000, Effects of JTV-519, a novel anti-ischaemic drug, on the delayed rectifier K+ current in Guinea-pig ventricular myocytes, Naunyn Schmiedeberg's Arch. Pharmacol., 361, 646, 10.1007/s002100000230 Kohno, 2003, A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure, Am. J. Physiol. Heart Circ. Physiol., 284, H1035, 10.1152/ajpheart.00722.2002 Lehnart, 2008, Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice, J. Clin. Invest., 118, 2230 Kobayashi, 2010, Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model, Circ. J., 74, 2579, 10.1253/circj.CJ-10-0680 Zhang, 2015, Non-beta-blocking R-carvedilol enantiomer suppresses Ca2+ waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure, Biochem. J., 470, 233, 10.1042/BJ20150548